Cargando…

Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage

INTRODUCTION: Diffuse alveolar hemorrhage (DAH) is a serious pulmonary complication seen in patients with autoimmune disorders and patients treated with chemotherapy or after hematopoietic stem cell transplantation. The clinical management of DAH is complex and the condition has a high mortality rat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heslet, Lars, Nielsen, Jorn Dalsgaard, Levi, Marcel, Sengeløv, Henrik, Johansson, Pär I
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794493/ https://www.ncbi.nlm.nih.gov/pubmed/17184515 http://dx.doi.org/10.1186/cc5132

Ejemplares similares

Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) – a review of a new treatment paradigm
por: Heslet, Lars, et al.
Publicado: (2012)

Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis
por: Mandal, S. K., et al.
Publicado: (2012)

Inhalation of activated protein C: A possible new adjunctive intervention in acute respiratory distress syndrome
por: Heslet, Lars, et al.
Publicado: (2007)

Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis
por: Khoulani, Dania, et al.
Publicado: (2014)

Successful hemostasis in refractory alveolar hemorrhage using low-dose recombinant activated factor VII
por: Selickman, John, et al.
Publicado: (2022)

Intrapulmonary administration of recombinant activated factor VII in diffuse alveolar haemorrhage: a report of two case stories
por: Estella, Ángel, et al.
Publicado: (2008)

Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer
por: Esper, Raúl Carrillo, et al.
Publicado: (2014)

Diffuse Alveolar Hemorrhage Associated with Makyo-kanseki-to Administration
por: Iida, Yuko, et al.
Publicado: (2016)

Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders
por: Johansson, Pär I, et al.
Publicado: (2010)

Risk factors of diffuse alveolar hemorrhage after acute ischemic stroke treated with tissue-type plasminogen activator. The effectiveness of activated recombinant factor VII treatment
por: Shimizu, Yu, et al.
Publicado: (2020)

Diffuse Alveolar Hemorrhage
por: Park, Moo Suk
Publicado: (2013)

Diffuse Alveolar Hemorrhage
por: Desai, Hem, et al.
Publicado: (2019)

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients
por: Park, Jeong A
Publicado: (2016)

Diffuse alveolar hemorrhage following sugammadex and remifentanil administration: A case report
por: Choi, Won Kyu, et al.
Publicado: (2019)

Diffuse alveolar hemorrhage in Wegener’s granulomatosis
por: Mahajan, Vineet, et al.
Publicado: (2011)

Lenalidomide-induced diffuse alveolar hemorrhage
por: Saheer, S., et al.
Publicado: (2014)

Diffuse Alveolar Hemorrhage Induced by Vaping
por: Agustin, Michael, et al.
Publicado: (2018)

Diffuse alveolar hemorrhage with nivolumab monotherapy
por: Shannon, Vickie R., et al.
Publicado: (2020)

Vaping-induced diffuse alveolar hemorrhage
por: Edmonds, Peter J., et al.
Publicado: (2020)

Diffuse alveolar hemorrhage secondary to sarcoidosis
por: Diaz-Menindez, Maximiliano, et al.
Publicado: (2023)

Sevoflurane-Induced Diffuse Alveolar Hemorrhage
por: Ahmed-Khan, Mohammad, et al.
Publicado: (2023)

Hemoptysis Due to Diffuse Alveolar Hemorrhage
por: Buchwald, Zoltan, et al.
Publicado: (2020)

Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery
por: Abdel-Meguid, Mohamed Essam
Publicado: (2013)

Successful management of warfarin-exacerbated diffuse alveolar hemorrhage using an extracorporeal membrane oxygenation
por: Lee, Jong Hoo, et al.
Publicado: (2013)

Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
por: Aggarwal, Anita, et al.
Publicado: (2004)

Life-threatening hemorrhage in neonates and children: treatment with activated recombinant factor VII
por: Fischer, D, et al.
Publicado: (2003)

Recombinant human activated factor VII in postpartum hemorrhagic shock: the dark side
por: van Veen, E. J. W., et al.
Publicado: (2007)

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage
por: Schneider, AS, et al.
Publicado: (2009)

Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage
por: Park, Soon Chang, et al.
Publicado: (2017)

Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia
por: Ansari, Amir M., et al.
Publicado: (2021)

Overview of the human pharmacokinetics of recombinant activated factor VII
por: Klitgaard, Thomas, et al.
Publicado: (2008)

METASTATIC ANGIOSARCOMA PRESENTING AS DIFFUSE ALVEOLAR HEMORRHAGE
por: Rai, SP, et al.
Publicado: (2008)

Diffuse Alveolar Hemorrhage Associated with Warfarin Therapy
por: Kaya, Bülent, et al.
Publicado: (2015)

Diffuse Alveolar Hemorrhage Associated with Edoxaban Therapy
por: Nitta, Kenichi, et al.
Publicado: (2016)

Mediastinal angiosarcoma presenting as diffuse alveolar hemorrhage
por: Datta, Debapriya, et al.
Publicado: (2018)

Cannabis Smoking-induced Diffuse Alveolar Hemorrhage
por: Alqahtani, Ali, et al.
Publicado: (2019)

Coexistence of Diffuse Alveolar Hemorrhage and Pulmonary Thromboembolism
por: Kurahara, Yu
Publicado: (2019)

Diffuse alveolar hemorrhage in children with trisomy 21
por: Bloom, Jessica L., et al.
Publicado: (2021)

Diffuse Alveolar Hemorrhage With Avelumab Maintenance Therapy
por: Li, Si, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_20e86l48s024kaob6thjn62n8t